These
pages, marked with GREEN headings, are published for comment
and criticism. These are not our final findings; some of
these opinions will probably change. LOG
OF UPDATES
Overview of
all studies: Because of the largely unexpected transformational
power of molecular manufacturing, it is urgent to understand the issues
raised. To date, there has not been anything approaching an adequate study
of these issues. CRN's recommended series of thirty
essential studies is organized into five sections, covering fundamental
theory, possible technological capabilities, bootstrapping potential,
product capabilities, and policy questions. Several preliminary conclusions
are stated, and because our understanding points to a crisis, a parallel
process of conducting the studies is urged.
CRN is actively
looking for researchers interested in performing or assisting with this
work. Please contact CRN Research Director Chris
Phoenix if you would like more information or if you have comments
on the proposed studies.
Study
#4
What
is the performance and potential of biological programmable manufacturing
and products?
Biology has been
making complex molecules and structures for billions of years, and self-replicators
already exist and produce cheap valuable products. Can this be harnessed
to produce engineered products?
Subquestion
Can the rules
of protein folding and self-assembly be accessed to design novel proteins,
structures, and machines?
Preliminary answer
Progress is preliminary,
but encouraging. A new protein fold has been designed and tested. In "Molecular
engineering: An approach to the development of general capabilities for
molecular manipulation" (PNAS, 78(9), Sept. 1981), Drexler pointed out
that protein engineering should be much easier than solving the protein
folding problem for natural proteins.
Subquestion
Can intracellular
transport mechanisms be adapted to increase the programmability of part
assembly?
Preliminary answer
Biological motors
have been extracted from cells and made to run. Programmability would
depend on whether some way other than diffusing chemicals could be found
to power them.
Subquestion
How efficiently
can new genetic specifications be synthesized and transferred into cells?
Preliminary answer
Progress is being
made... Study the cost per nucleotide vs. time. Also look at plasmid and
artificial chromosome development.
Subquestion
Can the rules
of multicellular structure formation (analogous to ontology or cellular
specialization) be accessed to design larger products?
Preliminary answer
Good question. MIT
work on amorphous computing may be relevant.
Subquestion
What would
be the performance of engineered systems based on biological materials,
with or without augmented biochemistry?
Preliminary answer
Strength: perhaps
comparable to modern polymers. Computation: with augmented chemistry,
could include molecular electronics. This depends largely on covalent
bond density.
Subquestion
What would
be the production speed of a biology-based manufacturing system?
Preliminary answer
Unknown.
Subquestion
What is the
smallest size (genome and physical) of a viable cell?
Preliminary answer
Unknown.
Subquestion
Can extracellular
protein synthesis systems improve any of these answers?
Preliminary answer
Unknown.
Conclusion
More
research will be needed to tell whether this technology can be revolutionary,
but it looks promising so far.
The situation is
extremely urgent. The stakes are unprecedented, and the world is unprepared.
The basic findings of these studies should be verified as rapidly as possible
(months, not years). Policy preparation and planning for implementation,
likely including a crash development program, should begin immediately.
(Sorry, no one has complained about this page yet, and we
couldn't think of anything to write. Please contact
us with your questions, criticisms, and other
suggestions.)